XENE Q4 2017 Earnings — Xenon Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

XENEXenon Pharmaceuticals Inc.

$5B

Q4 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$16,000-95.7% YoY

Gross Profit

-$6M-39881.3% margin

Operating Income

-$8M-50318.8% margin

Net Income

-$8M-50406.3% margin

EPS (Diluted)

$-0.45

QoQ Revenue Growth

-93.9%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$593,000

Balance Sheet

Total Assets

$46M

Total Liabilities

$10M

Stockholders' Equity

$36M

Cash & Equivalents

$20M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$16,000	$376,000	-95.7%
Gross Profit	-$6M	$368,000	-1834.0%
Operating Income	-$8M	-$5M	-47.4%
Net Income	-$8M	-$6M	-34.3%